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Introduction
The place where we spend the most important moments of 
our lives is a relevant issue to all of us. For instance, the 
debate about home versus hospital birth has been fuelled by 
observational studies, which suggest that planned home 
birth in many places can be as safe as planned hospital 
birth, and with fewer interventions and complications.1 
Equally, place of death has been of growing interest in pal-
liative and end-of-life care. There are several reasons for 
this. There is an international move to reduce hospital stays, 
to increase community support on the grounds of reducing 
iatrogenic disease, hospital-acquired infection, health-care 
costs and inappropriate lengthy hospital admissions and to 
more closely meet patient and family choice. In turn, meet-
ing patients’ and families’ preferences has been gaining 
Dying at home – is it better:  
A narrative appraisal of the state  
of the science
Irene J Higginson King’s College London, Cicely Saunders Institute, Department of Palliative Care, Policy 
and Rehabilitation, London, UK
Vera P Sarmento King’s College London, Cicely Saunders Institute, Department of Palliative Care, Policy 
and Rehabilitation, London, UK
Natalia Calanzani King’s College London, Cicely Saunders Institute, Department of Palliative Care, Policy 
and Rehabilitation, London, UK
Hamid Benalia King’s College London, Cicely Saunders Institute, Department of Palliative Care, Policy and 
Rehabilitation, London, UK
Barbara Gomes King’s College London, Cicely Saunders Institute, Department of Palliative Care, Policy and 
Rehabilitation, London, UK
Abstract
Background: Achieving home care and home death is increasingly used as an outcome measure of palliative care services.
Aim: To appraise the state of the science on dying at home.
Methods: Appraisal and narrative review developed from a plenary presentation at the European Association for Palliative Care 
(EAPC) 2012 meeting examining the research on variations and trends in place of death, factors associated with dying in the preferred 
place, presenting evidence on outcomes for those dying at home and suggesting future research questions.
Results: Meeting patients’ preferences and creating home-like environments has been a major concern for hospice and palliative 
care since its inception. During the 20th century, in many countries, hospital deaths increased and home deaths reduced. Despite the 
fact that this trend has been halted or reversed in some countries (notably the United States, Canada and, more recently, the United 
Kingdom) in the last 5–20 years, a home death is still a distant reality for the majority, even though evidence shows it is the most 
commonly preferred place to die. Epidemiological studies identified factors associated with home death, including affluence, patients’ 
preferences, provision of home care and extended family support. Evidence about the benefits of home care is conflicting, but recent 
data suggest that holistic well-being may be greater at home.
Implications: We call for further analyses of variations in place of care and place of death and robust studies on how patients 
and families formulate and change preferences over time. Regular monitoring of outcomes, quality and costs of palliative home 
care is urged.
Keywords
Home care, palliative care, patient preference, hospice, terminal care, end-of-life care
Corresponding author:
Irene J Higginson, Department of Palliative Care, Policy & Rehabilitation, Cicely Saunders Institute, King’s College London, Bessemer Road, London 
SE5 9PJ, UK. 
Email: irene.higginson@kcl.ac.uk
487940 PMJ271010.1177/0269216313487940Palliative MedicineHigginson et al.
2013
Invited Article
 at The University of Edinburgh on September 24, 2014pmj.sagepub.comDownloaded from 
Higginson et al. 919
relevance in the last years due to the increased recognition 
for the need to empower patients and families (with 
advanced care planning for instance) and to support patients 
with chronic non-malignant diseases.2
Alongside these general trends, striving for a home or 
‘home like’ environment has always been an important 
part of palliative care. In the United Kingdom, Dr Cicely 
Saunders3 developed inpatient hospices as an alternative 
to hospitals, where the hospice staff are the ‘hosts’ to 
patients and their families and provide a more home-like 
environment. Soon after, she and her colleague Dr Mary 
Baines recognised the need to feed the principles back to 
the patients’ own homes.4,5 There was a drive in the United 
Kingdom and Italy to find ways to offer treatments for 
complex problems, which had usually required hospitali-
sation, such as intestinal obstruction, and studies showed 
that obstruction could be managed out of hospitals and in 
an inpatient hospice or at home with good patient quality 
of life.6,7 In the United States, from the outset, hospices 
had a strong emphasis on home care and on patients 
spending the majority of their time at home and/or dying 
at home.8–10
Nowadays, this debate is increasingly relevant for all 
palliative care stakeholders and constitutes a public health 
issue due to the rising numbers of deaths and increasing 
health expenditure. Evidence from systematic reviews sug-
gests home palliative care results in higher caregivers’ and 
patients’ satisfaction,11,12 reduced length of stay in hospi-
tals11 and greater odds of dying at home.13,14 However, 
work is still needed to understand which components of the 
intervention provide the highest benefit.11,15
Variations and trends in place of 
death: international, national and 
local
Many outcomes (e.g. morbidity and mortality) vary by 
socio-economic status, and therefore, early research in this 
field examined whether home death could be similarly 
influenced. Clinicians working in community palliative 
care teams witness the value that patients and families place 
on being at home. It is a familiar environment where they 
maintain control and greater freedom than in hospital or 
even inpatient hospice.
This led to a preliminary investigation of the variation 
in home deaths for people who died from cancer. Higginson 
et al.16 studied the 5-year average proportion of home 
deaths in 44 electoral wards (voting districts with a popu-
lation of 3819–11,350) in one London district. The most 
striking finding was the degree of variation. In one elec-
toral ward, 5% of cancer deaths were at home, and in 
another, 46% were at home. There was an inverse correla-
tion between home death and social deprivation, as 
assessed by underprivileged area score – an index of 8 
aspects of affluence or not (Spearman Rho = −0.63 (95% 
confidence interval (CI): −0.44 to −0.79)), so that in poorer 
areas, fewer cancer patients died at home, but this did not 
explain all the variation.
The degree of social variation in the part of London 
where the study was conducted was large – ranging from 
the so called ‘boulevard of billionaires’ in Kensington to 
the highly socially deprived areas in northwest London. 
However, subsequent whole population research confirmed 
the high level of variation (from <10% to >65% in England) 
and the inverse relationship between social deprivation and 
home cancer death.17,18 The project disseminated to each 
district in the United Kingdom their individual data on 
place of death to raise awareness of the issues. The degree 
of inequity was supported internationally by the research of 
Pritchard et al.,19 Weitzen et al.20 and Mitchell et al.,19–21 
which was simultaneously studying variation in the United 
States using the Brown Atlas and empirical studies, and by 
the study of Costantini et al.22 in Genoa, Italy.
Finding information on real-time variation in place of 
death by local authority (which includes several electoral 
wards) in England is now made possible by the work of Dr 
Julia Verne and colleagues at the South West Public Health 
Observatory (SWPHO). English areas can immediately and 
freely find information on the proportion of home, hospital 
or hospice deaths, how they compare with other areas in 
England or within their region, plus much other demo-
graphic information, via the new UK End of Life Care 
Intelligence Network (http://www.endoflifecare-intelligence.
org.uk), a national collaboration created and supported by 
the UK End of Life Care Strategy.
During the 1990s and 2000s, home death proportions 
increased in Canada and the United States, while they fell 
in much of Europe. Between 1994 and 2004, the proportion 
of hospital deaths in Canada fell from 77.7% to 60.6%, 
while home death proportions increased from 19.3% to 
29.5%.23 In the United States, the percentage of Americans 
dying as hospital inpatients decreased from 54% to 41% 
between 1980 and 1998.24 The US Hospice Care Benefit 
was introduced in 1982 and may have influenced this 
shift.25 Disappointingly, for the United Kingdom, during 
the period 1984–1999, despite the growth in palliative care 
and hospice services, there was no change in the proportion 
of home cancer deaths, and the gap between poor and rich 
areas remained unchanged.18 A subsequent analysis from 
1974 to 2003 also showed an overall slow steady fall in 
home deaths, with home death proportions falling fastest in 
the oldest age groups and among non-cancer patients.26 
However, because of encouragement to the UK End of Life 
Care Strategy introduced in 2004, since 2005, there has 
been a small increase in home cancer deaths (from 22.1% 
to 27.3%) and home non-cancer deaths (from 16.7% to 
18.2%). Population-based data also found home death 
increases in some regions of Europe – for example, in 
Genoa (Italy), a home palliative care team appeared to have 
increased home deaths.22,27
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National policies introduced in other European countries 
may now help to improve palliative care for patients and 
families and allow care and dying in the place of choice. 
These include the following: the German 2007 Law for pro-
vision of specialist outpatient palliative care;28 the Belgian 
1998 Law of one home care team with two nurses and one 
doctor for 100 patients or per 300,000 inhabitants;29 the 
French 2002 national palliative care programme to establish 
palliative home care, palliative care units and campaign to 
raise awareness among population;29 and the Italian 2010 
Law of continuity between hospice and home care.30 
Considerable international variations exist in place of death 
from cancer, but this is harder to interpret than within coun-
try variations because of many differences in national poli-
cies, coding systems and cultural expectations.31,32
What do people actually want?
Many studies have researched preferences for both place of 
care and place of death in cancer in different populations and 
contexts and with different questions. Place of care and place 
of death are not the same, but preferences are associated. 
Asking the question in different ways (where do you think 
you would be best cared for or where would you ideally like 
to be) gives different responses. Therefore, research in this 
field needs to develop consistent methods. For place of death, 
there is consistent evidence across many studies that home is 
the main preference (25%–87% favouring home deaths, 
depending on whether the question was asked to patients, car-
egivers or general population),33 and in many studies, this is 
followed by a preference for inpatient hospice (9%–30%). 
Hospital and nursing homes have lower preferences.34 Robust 
international population-based evidence now comes from the 
PRISMA (Reflecting the Positive diveRsities of European 
prIorities for reSearch and Measurement in end of life cAre) 
survey of 9344 citizens across seven European countries, 
where home preference ranged from 51% (Portugal) to 84% 
(Netherlands) and hospice preference from 9% (Flanders) to 
29% (England).35 Longitudinal studies of place of death pref-
erences in patients approaching the end of life have shown 
that some patients shift their preference, away from home and 
towards inpatient hospice or other inpatient setting. 
Nonetheless, even in these studies, home remained the prefer-
ence for the majority,36,37 with some variation probably due to 
how the question was asked. Recent work has suggested that 
for many, preferences are stable.38 There are differences in 
preferences among different groups – for example, among 
older people or those with different cultures. However, this 
should not be assumed, as preferences among UK cancer 
patients from the Black Caribbean culture were found to be 
similar to those from White patients.39
It is also worth considering what a preference means and 
how it is formed. A preference will be affected by prior 
experiences (good and bad), those of friends and recent 
experiences of how services have worked, as well as the 
patient’s condition and the views of family and friends. A 
shift in preference may be influenced by, for example, care 
at home breaking down or failing, particularly good (or 
poor) experiences in hospital or inpatient hospice, physical 
symptoms or perception of family burden. The reasons for 
change in preferences are currently poorly studied and need 
further research.33,34
Furthermore, there are different forms of preference. In 
a longitudinal study, Townsend et al.37 distinguished 
between a preference in ‘ideal’ circumstances and one in 
‘existing circumstances’. Over time, these two forms of 
preferences diverged, the proportion of patients who stated 
a preference for home death given ‘existing circumstances’ 
fell from 59% to 48%, and the preference in ideal circum-
stances for home death increased from 67% to 70%. If pref-
erences in ‘ideal’ and ‘existing’ circumstances are different, 
then it would be valuable to understand the gap and the 
reasons for this. Moreover, preferences may exist along a 
continuum40 rather than being one choice versus a diametri-
cally opposed choice. It may be helpful to understand more 
about the interplay of different factors influencing prefer-
ences and how they change over time. Figure 1 illustrates 
three possible preference trajectories assuming that the 
preference in ideal circumstances remains stable and there 
is always a gap between ideal and existing circumstances.
Time Time Time
PreferenceIDEAL CIRCUMSTANCES IDEAL CIRCUMSTANCES
EXISTING CIRCUMSTANCES
Preference
Trajectory a
Preference
EXISTING CIRCUMSTANCES
IDEAL CIRCUMSTANCES
EXISTING CIRCUMSTANCES
Trajectory b Trajectory c
Figure 1. Three possible preference trajectories for place of care or death: preference of desired place of care or death; preference 
in ideal circumstances, for example, ‘Where would you like to be cared for or to die if it was possible?’ and preference in existing 
circumstances, for example, ‘Given your current circumstances and arrangements, where would you like to be cared for or die?’
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In trajectory a in Figure 1, the gap increases because the 
preference decreases with time ‘given existing circum-
stances’. In trajectory b, a small gap is maintained at a con-
stant level because existing circumstances remained stable. 
In trajectory c, the gap fluctuates due to changes in existing 
circumstances. These models do not comprehensively rep-
resent all possible preference trajectories, but they highlight 
the importance of understanding the dynamics of the pro-
cesses that determine preferences. The gap between ideal 
and existing circumstances might help explain why patients 
change their minds and sometimes express different prefer-
ences for place of care and place of death. Understanding 
reasons for the gap would allow health-care providers to 
identify potentially changeable factors that could approxi-
mate ideal and existing circumstances. In a longitudinal 
study, Thomas et al.40 identified four thematic domains of 
factors influencing preferences for place of death: the infor-
mal care resource, management of the body, experience of 
services and existential perspectives. These findings need to 
be appraised in larger samples and other settings.
What factors are associated with 
home care and home death?
Inequities continue to exist in place of death. Those from 
lower socio-economic groups or living in poorer areas are 
less likely to die at home.13,41,42 Culture and ethnicity affect 
place of death. Analysis of data from 68,804 patients resi-
dent in South East England, who died of cancer, found that 
following adjustment for confounders, death in a hospice 
was significantly less likely for Pakistani patients (odds 
ratio (OR) = 0.47, 95% CI = 0.30–0.74), Indian patients 
(OR = 0.68, 95% CI = 0.55–0.84) and Bangladeshi patients 
(OR = 0.33, 95% CI = 0.19–0.56). Furthermore, death at 
home was significantly less likely in Black African patients 
(OR = 0.48, 95% CI = 0.36–0.65), Black Caribbean patients 
(OR = 0.78, 95% CI = 0.67–0.90) and Chinese patients (OR 
= 0.46, 95% CI = 0.28–0.76). Pakistani, Indian, Bangladeshi, 
Black African, Black Caribbean and Chinese patients were 
all significantly more likely than White patients to die in 
hospital.43 People living in metropolitan areas are less 
likely to die at home.44,45 The relationship between age and 
place of death is more complex. In the United Kingdom and 
many countries, older people with cancer are less likely to 
die at home and in inpatient hospices.46 Indeed, in the 
United Kingdom, hospital is the most common place of 
death up to the age of 90 years when nursing home takes 
over.46 Diversely, in New York and in Singapore, home 
deaths increase with age.41,47
In order to enable more cancer patients to die at home 
and to tackle inequities, an understanding of the factors 
associated with death at home is required. Despite the pre-
dominance of a preference to die at home and increases in 
cancer home deaths in Canada, the United Kingdom and 
the United States, a home death is still far from being a real-
ity for the majority of people dying of cancer in these and 
other countries.23,24,32,35,48 A conceptual model developed in 
2006 continues to find empirical support from many differ-
ent studies.13 The model grouped risk factors into those 
related to the illness, the individual and the environment, 
the latter being the most important group in influencing 
death at home. Through systematic review, the authors 
found high-strength evidence for the effect of 17 factors, of 
which six were strongly associated with home death: 
patient’s low functional status (adjusted OR (AOR) = 2.29–
11.1), their preferences (AOR = 2.19–5.47), home care 
(AOR = 1.37–5.1) and its intensity (AOR = 1.06–8.65), liv-
ing with relatives (AOR = 1.78–7.85) and extended family 
support (AOR = 2.28–5.47). New evidence from recent 
systematic reviews suggests that home palliative care ser-
vices also increase the odds of home death, compared to 
usual care.14,49 The model now requires greater testing, ide-
ally comparing the relative contribution of factors in single 
studies. Social conditions, preferences and home care are 
factors that must also be better understood.
Is home care or home death better 
than other places – for example, 
the hospital?
Understanding whether people’s experiences of the dying 
process and its outcomes differ by place of death is vital. We 
still do not know whether dying at home is better than dying 
in hospital for patients and families. There is some evidence 
suggesting that psychological, social and holistic measures 
of the patient’s well-being in the last weeks or days of life 
may be better for patients dying at home.50–53 However, the 
findings regarding symptoms and family outcomes are not 
consistent enough to support that dying at home is better, 
worse or similar to dying in institutional settings.
The evidence is particularly disparate for the two most 
researched outcomes: pain and grief. Since Parkes’54 study 
in 1967–1971 in London, studies have been showing con-
flicting findings. Seven more recent studies showed incon-
sistencies in what was considered a ‘home death’, in the 
measurement of pain and in the groups compared.50,54–60 
This highlights the need for greater clarity and consistency 
in measurement and patient selection.
There is divergence also regarding the experience of 
death at home on the family. Using UK data from the 
Regional Study of Care of the Dying (RSCD) in 1990 on 
four grief-related binary questions, Addington-Hall and 
Karlsen61 reported greater grief when death took place at 
home. Quite the opposite, the US longitudinal study Coping 
with Cancer (2002–2008) found that relatives of patients 
who died in hospital were more likely to develop a pro-
longed grief disorder 6 months after (assessed using the 
validated Prolonged Grief Disorder Scale), than those who 
experienced a death at home with hospice care (AOR = 
8.83, 95% CI = 1.512–51.77, adjusted for baseline pre-loss 
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grief).51 Differences between home deaths with and without 
hospice care and intensive care unit deaths did not reach 
statistical significance. None of five other studies (all but 
one conducted with relatives of patients who received pal-
liative care) found associations between grief and place of 
death, four of which used the Texas Revised Inventory of 
Grief (TRIG).51,61–66 There remains a lack of population-
based studies, which adjust for prior relationship, and a 
need for new evidence to clarify this.
Implications for the future of 
research in this field
Data on place of death are easily accessed in many coun-
tries, making this a useful and practical outcome that can be 
compared cross-nationally and across regions within the 
same country. Epidemiological analyses have shown that 
information on place of death is valuable for planning ser-
vice provision, detecting regional or other inequities and 
changing trends. Therefore, the continued monitoring of 
place of death can support evidence-based decisions about 
health-care development and organisation, by uncovering 
emergent population needs and facilitating the comparison 
between different regions.
Alongside these epidemiological analyses, we also need 
information about patient and caregiver outcomes, the 
extent to which individual preferences are met and the 
quality of care and death, which is the ultimate quality indi-
cator. Such data will be vital in recording how place, out-
comes, experience, quality and costs are related. One means 
to achieve this would be to put in place routine monitoring, 
in practice, of patients’ experiences and outcomes. 
Retrospective surveys are helpful but rely on the relatives’ 
views; these may be especially prone to recall bias regard-
ing prior preferences for place of death. The Qualycare 
questionnaire and the Toolkit of Instruments to Measure 
End-of-life Care (TIME) are two examples of retrospective 
questionnaires that can be used to assess the quality of care 
and death. Prospective measurement of quality and out-
comes are needed, using brief validated transferable meas-
ures such as the Palliative Care Outcome Scale or Edmonton 
Symptom Assessment System,67,68 perhaps incorporated 
into monitoring systems similar to the Australian Palliative 
Care Outcomes Initiative.69
A better understanding of the factors influencing prefer-
ences for place of care and death, including age, culture, 
social conditions or previous care experiences, could inform 
the model of factors affecting place of death and contribute 
to the development of responsive palliative care services and 
clinical practice. Understanding the evolution of the gap 
between preferences in ‘ideal’ and ‘existing’ circumstances 
and also how previous experiences influence these would 
help build evidence on the importance and meaning of pref-
erences. Questions to assess preferences should be carefully 
chosen and piloted whenever possible. Further studies 
assessing preferences in ideal and existing circumstances, 
building on those of Townsend and other, would be valuable.
Limitations of this narrative review
According to Mays et al.,70 narrative reviews ‘summarize, 
explain and interpret evidence on a particular topic/ques-
tion’, dealing with studies’ findings and interpretations 
without attempting to synthesize them, with a less system-
atic and explicit approach, allowing for different types of 
evidence to be reviewed without generating completely 
new theories. This is the case here where we aimed to con-
sider the state of the science and how the studies evolved 
over time to lead to current knowledge. It is possible that 
we have missed some aspects, which might have been 
detected in a systematic review. However, systematic 
reviews tend to ask specific questions and are not suited for 
providing an overview of a topic or field.
Conclusion
Since the early stages of the modern hospice movement, there 
has been an awareness of the great value patients and families 
place on being at home. Epidemiological studies show that 
trends of increasing hospital deaths are changing in some 
countries, but death at home is still not a reality for the major-
ity and large variations remain. Preferences for place of care 
and death show that home is the main preference, followed by 
hospice, but there is a need for a greater understanding of fac-
tors underlying change of preferences and how often or why 
these change over time. Factors influencing home death sug-
gest that inequities and unmet needs in this setting still exist. 
Ensuring the best palliative care in all settings is essential, but 
in order to meet people’s preferences, investment should 
focus on services that make a difference, such as home pallia-
tive care services. Measures to support family carers should 
be implemented, and more data are needed on cost-effective-
ness of care, especially palliative home care. Measuring out-
comes prospectively is important to capture experiences, 
alongside the more easily measurable place of death.
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